Reprimo (RPRM) is a tumor-suppressor gene that has been found to be involved in the progression of a variety of malignant tumors such as pituitary tumors, gastric cancer, etc., and thus may serve as a biomarker for early cancer detection [17,18,19,20]. This evidence concerns the gene RPRM and cancer.